Adrien Samson | Healthcare Policy Senior Manager
EuropaBio
At EuropaBio, the European Association for Bioindustries, Adrien leads the development and implementation of the association's policy and advocacy strategy on healthcare biotech issues. Adrien works with a diverse range of stakeholders, including policymakers, regulators, industry representatives, patient groups, and research organizations, to promote the benefits and potential of biotech for health and society.
Appearances:
Day 1 - Wednesday 23 October @ 16:40
Panel: EU General Pharmaceutical Legislation – Europe’s Biotech Innovation for Rare Diseases in the Balance?
On 24 January 2024, EuropaBio published a new study analysing the expected impact of the GPL on the biotechnology innovation ecosystem which concluded that the GPL would have significant impact on innovation for rare diseases in the future.
-What would be the expected impact of the GPL on biotech innovation and innovators for rare diseases?
-What improvements can be made to ensure a sustained flow and growth of biotech innovation for rare diseases?
Day 3 - Friday 25th October @ 11:20
Panel: A New Beginning? The EU Biotechnology and Biomanufacturing Initiative Opportunities for Investment into Rare Disease Innovation and delivery
Day 3 - Friday 25th October @ 13:40
Panel: Join together to optimize ATMP development pathways in the EU
More to be confirmed..
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events